妇科分子影像:超越肿瘤范畴
该综述指出妇科疾病约占全球疾病负担的4.5%,良性妇科疾病如子宫内膜异位症、多囊卵巢综合征和子宫肌瘤研究不足。文章探讨了PET、SPECT、MRI和荧光成像在良性妇科疾病诊疗中的近期进展,重点关注近期临床报告、需求领域和增长机会。
要点
- 妇科疾病约占全球疾病负担的4.5%。
- 良性妇科疾病如子宫内膜异位症、多囊卵巢综合征和子宫肌瘤研究不足。
- 综述聚焦PET、SPECT、MRI和荧光成像在良性妇科疾病中的应用进展。
核心结论
- 分子影像可能有助于改善良性妇科疾病诊断和治疗两方面的患者照护。
研究设计与样本
- 本文为聚焦分子影像的综述,检索范围未在摘要中报告。
主要发现
- 综述考察了PET、SPECT、MRI和荧光成像在良性妇科疾病诊断和管理中的近期进展。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gynecological pathologies account for approximately 4.5% of the overall global disease burden. Although cancers of the female reproductive system have understandably been the focus of a great deal of research, benign gynecological conditions-such as endometriosis, polycystic ovary syndrome, and uterine fibroids-have remained stubbornly understudied despite their astonishing ubiquity and grave morbidity. This historical inattention has frequently become manifested in flawed diagnostic and treatment paradigms. Molecular imaging could be instrumental in improving patient care on both fronts. In this Focus on Molecular Imaging review, we will examine recent advances in the use of PET, SPECT, MRI, and fluorescence imaging for the diagnosis and management of benign gynecological conditions, with particular emphasis on recent clinical reports, areas of need, and opportunities for growth.
引用
- Sebastiano J, Rodriguez C, Samuels ZV, et al. Molecular Imaging in Gynecology: Beyond Cancer. J Nucl Med. 2024. PMID: 38871386. doi:10.2967/jnumed.124.267546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。